Hyphal-associated protein expression is crucial for Candida albicans-induced eicosanoid biosynthesis in immune cells.


Journal

European journal of immunology
ISSN: 1521-4141
Titre abrégé: Eur J Immunol
Pays: Germany
ID NLM: 1273201

Informations de publication

Date de publication:
Mar 2024
Historique:
revised: 03 01 2024
received: 29 08 2023
accepted: 04 01 2024
medline: 18 3 2024
pubmed: 18 1 2024
entrez: 17 1 2024
Statut: ppublish

Résumé

Candida albicans causes opportunistic infections ranging from mucosal mycoses to life-threatening systemic infections in immunocompromised patients. During C. albicans infection, leukotrienes and prostaglandins are formed from arachidonic acid by 5-lipoxygenase (5-LOX) and cyclooxygenases, respectively to amplify inflammatory conditions, but also to initiate macrophage infiltration to achieve tissue homeostasis. Since less is known about the cellular mechanisms triggering such lipid mediator biosynthesis, we investigated the eicosanoid formation in monocyte-derived M1 and M2 macrophages, neutrophils and HEK293 cells transfected with 5-LOX and 5-LOX-activating protein (FLAP) in response to C. albicans yeast or hyphae. Leukotriene biosynthesis was exclusively induced by hyphae in neutrophils and macrophages, whereas prostaglandin E

Identifiants

pubmed: 38233139
doi: 10.1002/eji.202350743
doi:

Substances chimiques

Eicosanoids 0
Leukotrienes 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2350743

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : 210879364
Organisme : Deutsche Forschungsgemeinschaft
ID : GA-2101/2-1
Organisme : Deutsche Forschungsgemeinschaft
ID : 434385622/GR 5617/1-1

Informations de copyright

© 2024 The Authors. European Journal of Immunology published by Wiley-VCH GmbH.

Références

Xu, S. and Shinohara, M. L., Tissue-resident macrophages in fungal infections. Front Immunol. 2017;8: 1798.
Desai, J. V. and Lionakis, M. S., The role of neutrophils in host defense against invasive fungal infections. Curr Clin Microbiol Rep. 2018. 5: 181-189.
Funk, C. D., Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 2001. 294: 1871-1875.
Gerstmeier, J., Weinigel, C., Rummler, S., Radmark, O., Werz, O. and Garscha, U., Time-resolved in situ assembly of the leukotriene-synthetic 5-lipoxygenase/5-lipoxygenase-activating protein complex in blood leukocytes. FASEB J. 2016. 30: 276-285.
Thulasingam, M. and Haeggstrom, J. Z., Integral membrane enzymes in eicosanoid metabolism: structures, mechanisms and inhibitor design. J Mol Biol. 2020. 432: 4999-5022.
Xue, J., Schmidt, S. V., Sander, J., Draffehn, A., Krebs, W., Quester, I., De Nardo, D. et al., Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity. 2014. 40: 274-288.
Martinez, F. O. and Gordon, S., The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 2014. 6: 13.
Werz, O., Gerstmeier, J., Libreros, S., De la Rosa, X., Werner, M., Norris, P. C., Chiang, N. et al., Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity. Nat Commun. 2018. 9: 59.
Jordan, P. M., Gerstmeier, J., Pace, S., Bilancia, R., Rao, Z., Borner, F., Miek, L. et al., Werz O. Staphylococcus aureus-derived alpha-hemolysin evokes generation of specialized pro-resolving mediators promoting inflammation resolution. Cell Rep. 2020. 33: 108247.
Brown, G. D., Denning, D. W. and Levitz, S. M., Tackling human fungal infections. Science. 2012. 336: 647.
Mayer, F. L., Wilson, D. and Hube, B., Candida albicans pathogenicity mechanisms. Virulence. 2013. 4: 119-128.
d'Enfert, C., Kaune, A. K., Alaban, L. R., Chakraborty, S., Cole, N., Delavy, M., Kosmala, D. et al., The impact of the fungus-host-microbiota interplay upon Candida albicans infections: current knowledge and new perspectives. FEMS Microbiol Rev. 2021. 45: fuaa060.
Sprague, J. L., Kasper, L. and Hube, B., From intestinal colonization to systemic infections: Candida albicans translocation and dissemination. Gut Microbes. 2022. 14: 2154548.
Jacobsen, I. D., Wilson, D., Wachtler, B., Brunke, S., Naglik, J. R. and Hube, B., Candida albicans dimorphism as a therapeutic target. Expert Rev Anti Infect Ther. 2012. 10: 85-93.
Lo, H. J., Kohler, J. R., DiDomenico, B., Loebenberg, D., Cacciapuoti, A. and Fink, G. R., Nonfilamentous C. albicans mutants are avirulent. Cell. 1997. 90: 939-949.
Staab, J. F., Bradway, S. D., Fidel, P. L. and Sundstrom, P., Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science. 1999. 283: 1535-1538.
Hoyer, L. L., Payne, T. L., Bell, M., Myers, A. M. and Scherer, S., Candida albicans ALS3 and insights into the nature of the ALS gene family. Curr Genet. 1998. 33: 451-459.
Moyes, D. L., Wilson, D., Richardson, J. P., Mogavero, S., Tang, S. X., Wernecke, J., Hofs, S. et al., Candidalysin is a fungal peptide toxin critical for mucosal infection. Nature. 2016. 532: 64-68.
Felk, A., Kretschmar, M., Albrecht, A., Schaller, M., Beinhauer, S., Nichterlein, T., Sanglard, D. et al., Candida albicans hyphal formation and the expression of the Efg1-regulated proteinases Sap4 to Sap6 are required for the invasion of parenchymal organs. Infect Immun. 2002. 70: 3689-3700.
Parti, R. P., Loper, R., Brown, G. D., Gordon, S., Taylor, P. R., Bonventre, J. V., Murphy, R. C. et al., Cytosolic phospholipase a2 activation by Candida albicans in alveolar macrophages: role of dectin-1. Am J Respir Cell Mol Biol. 2010. 42: 415-423.
Fischer, J., Gresnigt, M. S., Werz, O., Hube, B. and Garscha, U., Candida albicans-induced leukotriene biosynthesis in neutrophils is restricted to the hyphal morphology. FASEB J. 2021. 35: e21820.
Böyum, A., Separation of leucocytes from blood and bone marrow. With special reference to factors which influence and modify sedimentation properties of hematopoietic cells. Oslo, Universitetsforlaget. 1968. 108p.
Gerstmeier, J., Weinigel, C., Barz, D., Werz, O. and Garscha, U., An experimental cell-based model for studying the cell biology and molecular pharmacology of 5-lipoxygenase-activating protein in leukotriene biosynthesis. Biochim Biophys Acta. 2014. 1840: 2961-2969.
Gillum, A. M., Tsay, E. Y. and Kirsch, D. R., Isolation of the Candida albicans gene for orotidine-5'-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet. 1984. 198: 179-182.
Werner, M., Jordan, P. M., Romp, E., Czapka, A., Rao, Z., Kretzer, C., Koeberle, A. et al., Targeting biosynthetic networks of the proinflammatory and proresolving lipid metabolome. FASEB J. 2019. 33: 6140-6153.
Conrad, D. J., Kuhn, H., Mulkins, M., Highland, E. and Sigal, E., Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase. Proc Natl Acad Sci U S A. 1992. 89: 217-221.
Evans, J. H., Spencer, D. M., Zweifach, A. and Leslie, C. C., Intracellular calcium signals regulating cytosolic phospholipase A2 translocation to internal membranes. J Biol Chem. 2001. 276: 30150-30160.
Aharony, D. and Stein, R. L., Kinetic mechanism of guinea pig neutrophil 5-lipoxygenase. J Biol Chem. 1986. 261: 11512-11519.
Yun, B., Lee, H., Jayaraja, S., Suram, S., Murphy, R. C. and Leslie, C. C., Prostaglandins from cytosolic phospholipase A2alpha/cyclooxygenase-1 pathway and mitogen-activated protein kinases regulate gene expression in candida albicans-infected macrophages. J Biol Chem. 2016. 291: 7070-7086.
Tsatsanis, C., Androulidaki, A., Venihaki, M. and Margioris, A. N., Signalling networks regulating cyclooxygenase-2. Int J Biochem Cell Biol. 2006. 38: 1654-1661.
Lin, L. L., Wartmann, M., Lin, A. Y., Knopf, J. L., Seth, A. and Davis, R. J., Cpla2 is phosphorylated and activated by map kinase. Cell. 1993. 72: 269-278.
Zheng, X., Wang, Y. and Wang, Y., Hgc1, a novel hypha-specific G1 cyclin-related protein regulates Candida albicans hyphal morphogenesis. EMBO J. 2004. 23: 1845-1856.
Lionakis, M. S., Lim, J. K., Lee, C. C. and Murphy, P. M., Organ-specific innate immune responses in a mouse model of invasive candidiasis. J Innate Immun. 2011. 3: 180-199.
Staab, J. F., Datta, K. and Rhee, P., Niche-specific requirement for hyphal wall protein 1 in virulence of Candida albicans. PLoS One. 2013. 8: e80842.
Bailey, D. A., Feldmann, P. J., Bovey, M., Gow, N. A. and Brown, A. J., The Candida albicans HYR1 gene, which is activated in response to hyphal development, belongs to a gene family encoding yeast cell wall proteins. J Bacteriol. 1996. 178: 5353-5360.
Liu, Y. and Filler, S. G., Candida albicans Als3, a multifunctional adhesin and invasin. Eukaryot Cell. 2011. 10: 168-173.
Moyes, D. L., Runglall, M., Murciano, C., Shen, C., Nayar, D., Thavaraj, S., Kohli, A. et al., A biphasic innate immune MAPK response discriminates between the yeast and hyphal forms of Candida albicans in epithelial cells. Cell Host Microbe. 2010. 8: 225-235.
Maxson, M. E., Naj, X., O'Meara, T. R., Plumb, J. D., Cowen, L. E. and Grinstein, S., Integrin-based diffusion barrier separates membrane domains enabling the formation of microbiostatic frustrated phagosomes. Elife. 2018. 7: e34798.
Erwig, L. P. and Gow, N. A., Interactions of fungal pathogens with phagocytes. Nat Rev Microbiol. 2016. 14: 163-176.
Nobile, C. J., Nett, J. E., Andes, D. R. and Mitchell, A. P., Function of Candida albicans adhesin Hwp1 in biofilm formation. Eukaryot Cell. 2006. 5: 1604-1610.
Sundstrom, P., Balish, E. and Allen, C. M., Essential role of the Candida albicans transglutaminase substrate, hyphal wall protein 1, in lethal oroesophageal candidiasis in immunodeficient mice. J Infect Dis. 2002. 185: 521-530.
Romp, E., Arakandy, V., Fischer, J., Wolz, C., Siegmund, A., Loffler, B., Tuchscherr, L. et al., Exotoxins from Staphylococcus aureus activate 5-lipoxygenase and induce leukotriene biosynthesis. Cell Mol Life Sci. 2020. 77: 3841-3858.
Phan, Q. T., Solis, N. V., Cravener, M. V., Swidergall, M., Lin, J., Huang, M. Y., Liu, H. et al., Candida albicans stimulates formation of a multi-receptor complex that mediates epithelial cell invasion during oropharyngeal infection. PLoS Pathog. 2023. 19: e1011579.
Naglik, J. R., Konig, A., Hube, B. and Gaffen, S. L., Candida albicans-epithelial interactions and induction of mucosal innate immunity. Curr Opin Microbiol. 2017. 40: 104-112.
Austermeier, S., Kasper, L., Westman, J. and Gresnigt, M. S., I want to break free - macrophage strategies to recognize and kill Candida albicans, and fungal counter-strategies to escape. Curr Opin Microbiol. 2020. 58: 15-23.
Kanayama, M., Inoue, M., Danzaki, K., Hammer, G., He, Y. W. and Shinohara, M. L., Autophagy enhances NFkappaB activity in specific tissue macrophages by sequestering A20 to boost antifungal immunity. Nat Commun. 2015. 6: 5779.
Qian, Q., Jutila, M. A., Van Rooijen, N. and Cutler, J. E., Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J Immunol. 1994. 152: 5000-5008.
Sun, D., Sun, P., Li, H., Zhang, M., Liu, G., Strickland, A. B., Chen, Y. et al., Fungal dissemination is limited by liver macrophage filtration of the blood. Nat Commun. 2019. 10: 4566.
Jayaraja, S., Dakhama, A., Yun, B., Ghosh, M., Lee, H., Redente, E. F., Uhlson, C. L. et al., Cytosolic phospholipase A2 contributes to innate immune defense against Candida albicans lung infection. BMC Immunol. 2016. 17: 27.
Narumiya, S., Sugimoto, Y. and Ushikubi, F., Prostanoid receptors: structures, properties, and functions. Physiol Rev. 1999. 79: 1193-1226.
Sasaki, F. and Yokomizo, T., The leukotriene receptors as therapeutic targets of inflammatory diseases. Int Immunol. 2019. 31: 607-615.
Sumimoto, H., Takeshige, K. and Minakami, S., Superoxide production of human polymorphonuclear leukocytes stimulated by leukotriene B4. Biochim Biophys Acta. 1984. 803: 271-277.
Ford-Hutchinson, A. W., Bray, M. A., Doig, M. V., Shipley, M. E. and Smith, M. J., Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature. 1980. 286: 264-265.
Kalinski, P., Regulation of immune responses by prostaglandin E2. J Immunol. 2012. 188: 21-28.
Nakayama, T., Mutsuga, N., Yao, L. and Tosato, G., Prostaglandin E2 promotes degranulation-independent release of MCP-1 from mast cells. J Leukoc Biol. 2006. 79: 95-104.
Wang, X. S. and Lau, H. Y., Prostaglandin E potentiates the immunologically stimulated histamine release from human peripheral blood-derived mast cells through EP1/EP3 receptors. Allergy. 2006. 61: 503-506.
Strassmann, G., Patil-Koota, V., Finkelman, F., Fong, M. and Kambayashi, T., Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J Exp Med. 1994. 180: 2365-2370.
Noverr, M. C. and Huffnagle, G. B., Regulation of Candida albicans morphogenesis by fatty acid metabolites. Infect Immun. 2004. 72: 6206-6210.
Abdelmegeed, E. and Shaaban, M. I., Cyclooxygenase inhibitors reduce biofilm formation and yeast-hypha conversion of fluconazole resistant Candida albicans. J Microbiol. 2013. 51: 598-604.
Kalo-Klein, A. and Witkin, S. S., Prostaglandin E2 enhances and gamma interferon inhibits germ tube formation in Candida albicans. Infect Immun. 1990. 58: 260-262.
Peters, B. M. and Noverr, M. C., Candida albicans-Staphylococcus aureus polymicrobial peritonitis modulates host innate immunity. Infect Immun. 2013. 81: 2178-2189.
Willment, J. A., Lin, H. H., Reid, D. M., Taylor, P. R., Williams, D. L., Wong, S. Y., Gordon, S. et al., Dectin-1 expression and function are enhanced on alternatively activated and GM-CSF-treated macrophages and are negatively regulated by IL-10, dexamethasone, and lipopolysaccharide. J Immunol. 2003. 171: 4569-4573.
Brown, G. D., Herre, J., Williams, D. L., Willment, J. A., Marshall, A. S. and Gordon, S., Dectin-1 mediates the biological effects of beta-glucans. J Exp Med. 2003. 197: 1119-1124.
Hebecker, B., Vlaic, S., Conrad, T., Bauer, M., Brunke, S., Kapitan, M., Linde, J. et al., Dual-species transcriptional profiling during systemic candidiasis reveals organ-specific host-pathogen interactions. Sci Rep. 2016. 6: 36055.

Auteurs

Jana Schimanski (J)

Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Greifswald University, Greifswald, Germany.

Mark S Gresnigt (MS)

Junior Research Group Adaptive Pathogenicity Strategies, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute, Jena, Germany.

Elena Brunner (E)

Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich-Schiller University Jena, Jena, Germany.

Oliver Werz (O)

Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich-Schiller University Jena, Jena, Germany.

Bernhard Hube (B)

Department of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology-Hans Knoell Institute, Jena, Germany.
Institute for Microbiology, Friedrich Schiller University, Jena, Germany.

Ulrike Garscha (U)

Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Greifswald University, Greifswald, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH